Serology after ts-11 and MSH mycoplasma vaccination
Live ts mycoplasma vaccines were created to be safe but still immunogenic. So how can we assess this immunogenicity in the field? This bulletin condenses the experience of 20 years trying to monitor vaccine response and differentiate problems from normal responses. Various approaches have been taken to improve serological monitoring (for example, cloned homologous antigens) …
VIEW